Assessment of drug concentrations in tears in therapeutic drug monitoring: I. Determination of valproic acid in tears by gas chromatography/mass spectrometry with EC/NCI mode

Therapeutic Drug Monitoring

Volumn 22, Issue 6, 2000, Pages 716-722

  Nakajima, Masaharu ^a,e   Yamato, Susumu ^a   Shimada, Kenji ^a   Sato, Shinji ^a   Kitagawa, Shuji ^a   Honda, Akira ^b,c   Miyamoto, Jiro ^b,c   Shoda, Junichi ^f   Ohya, Masayuki ^d   Miyazaki, Hiroshi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b Miyamoto Hospital   (Japan)

^c UNIVERSITY OF TSUKUBA   (Japan)

^d Thermoquest Inc   (Japan)

^e Food Research Institute   (Japan)

^f NONE

Author keywords

GC MS; Plasma; Quantitation; Tears; Valproic acid

Indexed keywords

DRUG METABOLITE; VALPROIC ACID;

ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG MONITORING; GAS CHROMATOGRAPHY; HUMAN; LACRIMAL FLUID; MASS SPECTROMETRY; PRIORITY JOURNAL; QUANTITATIVE ASSAY;

ANTICONVULSANTS; CALIBRATION; DRUG MONITORING; EPILEPSY; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; SENSITIVITY AND SPECIFICITY; TEARS; VALPROIC ACID;

EID: 0033646555     PISSN: 01634356     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007691-200012000-00011     Document Type: Article

References (19)

1. Plasma protein binding kinetics of valproic acid over a broad dosage range: Therapeutic implications
2. The free fraction of valproic acid in tears, saliva, and cerebrospinal fluid
3. Greater reliability of tear versus saliva anticonvulsant levels
4. Tears as the best practical indicator of the unbound fraction of an anticonvulsant drug
5. Diphenylhydantoin and primidone in tears
6. Ethosuximide in tears, saliva, and cerebrospinal fluid
7. A longitudinal study of valproate free fraction in the specific age group at greatest risk for febrile convulsions (children below 3 years)
8. Serum, tear, and salivary concentrations of methotrexate in man
9. Simultaneous determination of six antiepileptic drugs by capillary gas chromatography
10. Determination of valproic acid in human plasma by capillary gas chromatography
11. Determination of valproic acid by high-performance liquid chromatography with photodiode-array and fluorescence detection
12. Determination of valproic acid and its metabolites using gas chromatography with mass-selective detection: Application to serum and urine samples from sheep
13. On-column gas chromatographic/mass spectrometric assay for metabolic profiling of valproate in brain tissue and serum
14. Valproic acid in breast milk: How much is really there?
15. Use of hexadeuterated valproic acid and gas chromatography-mass spectrometry to determine the pharmacokinetics of valproic acid
16. Fluorescence polarization immunoassay and enzyme immunoassay compared for free valproic acid in serum ultrafiltrates from epileptic patients
17. Negative ion chemical ionization gas chromatography/mass spectrometry of valproic acid metabolites
18. Methods to reduce background interferences in electron-capture gas chromatographic analysis of valproic acid and its unsaturated metabolites after derivatization with pentafluorobenzyl bromide